Management of ATherothrombosis with Clopidogrel in High-risk patients with recent TIA or ischemic stroke "MATCH"

Completed

Phase N/A Results

Summary of Purpose

To determine whether the combination of clopidogrel plus acetylsalicylic acid (ASA) is superior to clopidogrel alone in preventing ischemic events in patients with a recent TIA or ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 August 2004.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Sanofi-Synthelabo Recherche, France

Trial Design

International, randomized, double-blind, prospective, parallel-group trial with a planned enrollment of 7600 patients.

Contacts

Not available